| Antipsychotics and the risk of type 2 diabetes mellitus in children and youth WV Bobo, WO Cooper, CM Stein, M Olfson, D Graham, J Daugherty, ... JAMA psychiatry 70 (10), 1067-1075, 2013 | 285 | 2013 |
| Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ethnicity WA Rocca, CM Boyd, BR Grossardt, WV Bobo, LJF Rutten, VL Roger, ... Mayo Clinic Proceedings 89 (10), 1336-1349, 2014 | 278 | 2014 |
| Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity JL St Sauver, CM Boyd, BR Grossardt, WV Bobo, LJF Rutten, VL Roger, ... BMJ open 5 (2), e006413, 2015 | 270 | 2015 |
| Antidepressant discontinuation syndrome CH Warner, W Bobo, C Warner, S Reid, J Rachal American family physician 74 (3), 449-456, 2006 | 265 | 2006 |
| Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies. HY Meltzer, WV Bobo, IF Nuamah, R Lane, D Hough, M Kramer, ... Journal of Clinical Psychiatry 69 (5), 817-829, 2008 | 243 | 2008 |
| The PHQ-9 Item 9 based screening for suicide risk: a validation study of the Patient Health Questionnaire (PHQ)− 9 Item 9 with the Columbia Suicide Severity Rating Scale (C-SSRS) PJ Na, SR Yaramala, JA Kim, H Kim, FS Goes, PP Zandi, JLV Voort, ... Journal of affective disorders 232, 34-40, 2018 | 210 | 2018 |
| A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. HY Meltzer, WV Bobo, A Roy, K Jayathilake, Y Chen, A Ertugrul, ... Journal of Clinical Psychiatry 69 (2), 274-285, 2008 | 207 | 2008 |
| Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations PM Maki, SG Kornstein, H Joffe, JT Bromberger, EW Freeman, ... Journal of women's health 28 (2), 117-134, 2019 | 200* | 2019 |
| Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study J Westman, SV Eriksson, M Gissler, J Hällgren, ML Prieto, WV Bobo, ... Epidemiology and Psychiatric Sciences 27 (5), 519-527, 2018 | 163 | 2018 |
| Prevalence and trends in the use of antipsychotic medications during pregnancy in the US, 2001–2007: a population-based study of 585,615 deliveries S Toh, Q Li, TC Cheetham, WO Cooper, RL Davis, S Dublin, TA Hammad, ... Archives of women's mental health 16, 149-157, 2013 | 147 | 2013 |
| Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations PM Maki, SG Kornstein, H Joffe, JT Bromberger, EW Freeman, ... Menopause 25 (10), 1069-1085, 2018 | 143 | 2018 |
| Increasing pregnancy-related use of prescribed opioid analgesics RA Epstein, WV Bobo, PR Martin, JA Morrow, W Wang, R Chandrasekhar, ... Annals of epidemiology 23 (8), 498-503, 2013 | 143 | 2013 |
| Concise review for physicians and other clinicians: postpartum depression WV Bobo, BP Yawn Mayo Clinic Proceedings 89 (6), 835-844, 2014 | 123 | 2014 |
| Ketamine for treatment‐resistant unipolar and bipolar major depression: Critical review and implications for clinical practice WV Bobo, JL Vande Voort, PE Croarkin, JG Leung, SJ Tye, MA Frye Depression and anxiety 33 (8), 698-710, 2016 | 122 | 2016 |
| Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE) LG Sylvia, RC Shelton, DE Kemp, EE Bernstein, ES Friedman, BD Brody, ... Bipolar disorders 17 (2), 212-223, 2015 | 116 | 2015 |
| Risk of myocardial infarction and stroke in bipolar disorder: a systematic review and exploratory meta‐analysis ML Prieto, AB Cuéllar‐Barboza, WV Bobo, VL Roger, F Bellivier, ... Acta Psychiatrica Scandinavica 130 (5), 342-353, 2014 | 115 | 2014 |
| Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder LG Sylvia, ES Friedman, JH Kocsis, EE Bernstein, BD Brody, G Kinrys, ... Journal of affective disorders 151 (2), 722-727, 2013 | 111 | 2013 |
| TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics M Gupta, D Neavin, D Liu, J Biernacka, D Hall-Flavin, WV Bobo, MA Frye, ... Molecular psychiatry 21 (12), 1717-1725, 2016 | 108 | 2016 |
| Continuation phase intravenous ketamine in adults with treatment-resistant depression JLV Voort, RJ Morgan, S Kung, KG Rasmussen, J Rico, BA Palmer, ... Journal of affective disorders 206, 300-304, 2016 | 103 | 2016 |
| The diagnosis and management of bipolar I and II disorders: clinical practice update WV Bobo Mayo Clinic Proceedings 92 (10), 1532-1551, 2017 | 100 | 2017 |
